🔎 Trials Near Me

Home › Scleroderma › Florida › Jacksonville

Scleroderma clinical trials in Jacksonville, FL

3 studies for Scleroderma are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

RecruitingPhase 1
  • Mayo Clinic, Jacksonville
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

RecruitingPhase 2/3
  • GSK Investigational Site, Jacksonville
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RecruitingPhase 2/3
  • Mayo Clinic Florida, Jacksonville
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777

About Scleroderma

Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.

More about Scleroderma on MedlinePlus

Scleroderma trials in other cities

Other studies in Jacksonville

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.